Navigation Links Website Offers Latest on Assessing Prostate Cancer Risk
Date:9/14/2010 Website Offers Latest on Assessing Prostate Cancer Risk -- NYON, Switzerland, September 15, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Web Site, Publishing & Information Services, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services Click to view news release full screen Website Offers Latest on Assessing Prostate Cancer Risk


NYON, Switzerland, September 15, 2010 /PRNewswire/ --

- Site Provides Information on New Blood Test and Unique Index to Help Reduce Unnecessary Biopsies - a major online resource to help assess risk for prostate cancer - is now available in five languages, English, French German, Italian and Spanish.

Created by the scientific team behind the world's largest independent medical diagnostics company - Beckman Coulter, Inc. (European headquarters in Nyon, Switzerland) - provides educational information for patients, physicians and clinical laboratory staff.

The newly launched site describes the medical research behind a new blood test (p2PSA), and the Prostate Health Index (phi), that scientists have created to significantly improve a patient's risk assessment for prostate cancer.

"The dilemma faced by men with an elevated prostate-specific antigen, or PSA test, is how to find out if they actually have prostate cancer," explained Peter Heseltine, M.D, medical director for Beckman Coulter. "That usually meant undergoing an invasive prostate biopsy. The search has been underway for several years to find a non-invasive way of assessing cancer risk."

And Dr. Heseltine added: "The Prostate Health Index (phi) provides clinicians with a way of combining and interpreting three blood tests that measure different forms of the PSA protein. The index is a risk assessment tool for prostate cancer. A low phi result indicates a lower risk of prostate cancer, while an elevated phi suggests that it may be appropriate to have a prostate biopsy."

The new website encourages dialogue between patients, physicians and laboratory professionals, and provides guidance and education, fostering more informed prostate biopsy decision-making. Included are links to medical resources and the latest scientific studies.

As one example, recent findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) showed a 30 percent mortality reduction from prostate cancer deaths if PSA levels were monitored over approximately seven years. So, while the current PSA test informs doctors there may be a problem with the prostate, it does not indicate what the specific problem is - cancer or no cancer.

Notes to Editor

Patient Leaflet

To obtain a free digital copy of the leaflet Do I need a prostate biopsy? simply send your e-mail address by filling out the form at

Research findings

These include a recent study published in The Journal of Urology, which confirmed that the phi score is a better predictor of prostate cancer risk than PSA or percent free PSA alone in men 50 years of age and older with a PSA range of 2-10 ng/mL who had a digital rectal exam with no suspicious findings.[1]


[1] Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, Catalona WJ. [-2] pro-PSA is more accurate than total and free PSA in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study. J of Urology 2010 April; 183(4):1355-1359.

The Beckman Coulter phi

This combines three automated blood tests into one index that estimates a man's probability of having prostate cancer found on biopsy. Beckman Coulter phi is a composite score of Access Hybritech PSA, free PSA and the new p2PSA (not available in the United States) assay, which measures the free PSA isoform [-2]proPSA. This assessment can only be carried out in a hospital or medically approved laboratory.

About Beckman Coulter

Beckman Coulter, Inc., a $3.3 billion company based in California, USA, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. For more information, visit

SOURCE Beckman Coulter Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millstone Medical Outsourcing Launches New, Improved Company Website
2. Medical Website Design Experts Aurora Information Technology Introduces Its Newest Website Launch, Muscat Eye Laser Center
3. Dynatronics Launches E-Commerce Website
4. China Medical Technologies Announces the Recent Publication of a Study on its SPR Analyzer and HPV DNA Chip in Cancer Genetics and Cytogenetics and the Creation of a Medical Publications Column to the Investor Relations Section on its Website
5. United Seating & Mobility Launches New Company Website and E-Commerce Store at
6. New Corporate Profile Posted On CardioGenics Website
7. Best Health Care Website of 2010 to be Named by Web Marketing Association in 14th Annual WebAward Competition
8. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
9. Should Any Vaccines Be Required for Children? Pros and Cons and Current Research at New Website
10. Vivakor Announces Launch of VivaThermic Website and Highlights Distribution & Sales of Its VivaThermic Products in Japan Through Veritas Corporation
11. Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website
Post Your Comments:
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
(Date:11/25/2015)... USA , Inc., a leader in ... accuracy of its blood glucose meter systems. Last week ... Cardiovascular Disease in Los Angeles , ... 01 meter and the Assure ® Prism multi-user ... measure glucose levels in blood is essential for people ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Allergan plc ... an agreement with the New York State ... 2 of the Sherman Act, and other statutes with the ... in February 2014, to cease marketing and selling the now ... of settlement, Allergan admits no liability, has released its counterclaims ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... Consistent with the Radiology Business Management ... Radiology Marketing Programs meeting will showcase some of the best 2015 radiology ... Palace in Las Vegas with a pre-conference session on a collaborative approach for ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and women ... healthcare organizations in the country. They have overseen financial turnarounds, shown commitment to ... the healthcare industry as a whole through their advocacy and professional efforts. , ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family ... tests directly from their electronic medical record (EMR) without the need for redundant ...
Breaking Medicine News(10 mins):